Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
Chirality|November 16, 2017
Biomimetic syntheses of racemic natural productsArie Zask, George EllestadChirality|October 11, 2021
Reflections on the intriguing occurrence of some recently isolated natural products as racemates and scalemic mixturesArie Zask, George A EllestadChirality|June 23, 2015
Recent Advances in Stereoselective Drug TargetingArie Zask, George A EllestadChirality|March 12, 2020
The enduring legacy of Koji Nakanishi's research on bioorganic chemistry and natural products. Part 1: Isolation, structure determination and mode of actionGeorge Ellestad, Arie Zask, Nina BerovaBiochemistry|November 30, 2005
Structure-based identification of the binding site for the hemiasterlin analogue HTI-286 on tubulinMalini Ravi, Arie Zask, Thomas S RushChirality|April 27, 2013
Biological stereoselectivity of atropisomeric natural products and drugsArie Zask, John Murphy, George A EllestadExpert Opinion on Therapeutic Patents|May 20, 2011
Recent advances in the discovery of small-molecule ATP competitive mTOR inhibitors: a patent reviewArie Zask, Jeroen C Verheijen, David J RichardCurrent Opinion in Drug Discovery & Development|July 3, 2010
Recent advances in the development of selective, ATP-competitive inhibitors of mTORDavid J Richard, Jeroen C Verheijen, Arie ZaskJournal of the American Chemical Society|December 15, 2005
Hybrids of the hemiasterlin analogue taltobulin and the dolastatins are potent antimicrotubule agentsArie Zask, Joshua Kaplan, Sylvia Musto, et al.Bioorganic & Medicinal Chemistry Letters|March 13, 2010
Triazines incorporating (R)-3-methylmorpholine are potent inhibitors of the mammalian target of rapamycin (mTOR) with selectivity over PI3KalphaDavid J Richard, Jeroen C Verheijen, Ker Yu, et al.Pageof 6